Harm Reduction

Advancing Harm Reduction Across Drug Policy

Harm reduction, public health, and human rights are at the core of this work across all drug categories. Through advocacy, education, and strategic partnerships, evidence-based drug policy reform is advanced to reduce risks, improve safety, and support more balanced regulatory frameworks worldwide.

Safer use focuses on practical strategies that reduce risks during drug consumption. Through education, dosage awareness, and safer practices, individuals are supported to make informed decisions, lowering the likelihood of overdose, injury, and preventable harm.
Safer supply addresses risks caused by unregulated drug markets. By promoting controlled access, quality standards, and transparency, these approaches reduce contamination, unpredictable potency, and overdose risks, improving safety and public health outcomes.
Accessible health services are essential to harm reduction, including testing, treatment, and support programs. These services reduce health risks, prevent overdoses, and connect individuals to care, improving outcomes and strengthening public health systems.
Effective drug policy tools such as decriminalisation, regulated supply models, and quality control reduce systemic harms. These evidence-based approaches shift focus from punishment to public health, improving safety, reducing illicit markets, and supporting human rights.
Community-led harm reduction initiatives provide trusted education, outreach, and peer support. Local organisations play a vital role in reducing stigma, improving access to services, and strengthening safer practices within affected communities.